Trulicity is a GLP-1 receptor agonist used for type 2 diabetes management, administered as a once-weekly subcutaneous injection
Ozempic Lawsuit: What To Do If You Were Injured Written by Terry Turner, Legally Reviewed by Jonathan M
Results showed that at week 24, the mean change in hepatic fat content relative to baseline was -42.9% in the 1mg group, -57.0% in the 4mg group, -81.4% in the 8mg group, and -82.4% in the 12mg group, compared to +0.3% in the placebo group
GLP-1 medications, such as semaglutide (Wegovy) or liraglutide (Saxenda), are often used for weight loss and managing type 2 diabetes, but they can be expensive
Through careful monitoring and personalized dosing, we help achieve optimal results while minimizing potential side effects